Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 355

1.

Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation.

Gaunitz F, Thomas A, Fietzke M, Franz F, Auwärter V, Thevis M, Mercer-Chalmers-Bender K.

Int J Legal Med. 2018 Dec 18. doi: 10.1007/s00414-018-1964-8. [Epub ahead of print]

PMID:
30564916
2.

Correction to: Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication.

Gaunitz F, Lehmann S, Thomas A, Thevis M, Rothschild MA, Mercer-Chalmers-Bender K.

Int J Legal Med. 2018 Dec 5. doi: 10.1007/s00414-018-1976-4. [Epub ahead of print]

PMID:
30515589
3.

Annual banned-substance review: Analytical approaches in human sports drug testing.

Thevis M, Kuuranne T, Geyer H.

Drug Test Anal. 2018 Nov 28. doi: 10.1002/dta.2549. [Epub ahead of print]

PMID:
30488582
4.

SARCOSYL-PAGE: Optimized Protocols for the Separation and Immunological Detection of PEGylated Proteins.

Reichel C, Gmeiner G, Reihlen P, Thevis M, Schänzer W.

Methods Mol Biol. 2019;1855:131-149. doi: 10.1007/978-1-4939-8793-1_14.

PMID:
30426415
5.

The 36th Manfred Donike workshop on doping analysis.

Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1633-1634. doi: 10.1002/dta.2536. Epub 2018 Nov 26. No abstract available.

PMID:
30394671
6.

Development of a mass spectrometry-based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes.

Knoop A, Thomas A, Thevis M.

Rapid Commun Mass Spectrom. 2018 Nov 5. doi: 10.1002/rcm.8337. [Epub ahead of print]

PMID:
30394592
7.

Studies on the in vivo metabolism of the SARM YK11: Identification and characterization of metabolites potentially useful for doping controls.

Piper T, Dib J, Putz M, Fusshöller G, Pop V, Lagojda A, Kuehne D, Geyer H, Schänzer W, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1646-1656. doi: 10.1002/dta.2527. Epub 2018 Nov 18.

PMID:
30379415
8.

Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: Impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway.

Nader E, Grau M, Fort R, Collins B, Cannas G, Gauthier A, Walpurgis K, Martin C, Bloch W, Poutrel S, Hot A, Renoux C, Thevis M, Joly P, Romana M, Guillot N, Connes P.

Nitric Oxide. 2018 Dec 1;81:28-35. doi: 10.1016/j.niox.2018.10.003. Epub 2018 Oct 19.

PMID:
30342855
9.

Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry.

Thomas A, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1761-1768. doi: 10.1002/dta.2518. Epub 2018 Nov 8.

PMID:
30298989
10.

Combined detection of the ActRII-Fc fusion proteins Sotatercept (ActRIIA-Fc) and Luspatercept (modified ActRIIB-Fc) in serum by means of immunoaffinity purification, tryptic digestion, and LC-MS/MS.

Walpurgis K, Thomas A, Lange T, Reichel C, Geyer H, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1714-1721. doi: 10.1002/dta.2513. Epub 2018 Oct 30.

PMID:
30285318
11.

Effects of 3 Weeks of Oral Low-Dose Cobalt on Hemoglobin Mass and Aerobic Performance.

Hoffmeister T, Schwenke D, Krug O, Wachsmuth N, Geyer H, Thevis M, Byrnes WC, Schmidt WFJ.

Front Physiol. 2018 Sep 19;9:1289. doi: 10.3389/fphys.2018.01289. eCollection 2018.

12.

Recent improvements in sports drug testing concerning the initial testing for peptidic drugs (< 2 kDa) - sample preparation, mass spectrometric detection, and data review.

Görgens C, Guddat S, Thomas A, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1755-1760. doi: 10.1002/dta.2503. Epub 2018 Nov 8.

PMID:
30239151
13.

Case Study: Atypical δ13 C values of urinary norandrosterone.

Hülsemann F, Gougoulidis V, Schertel T, Fusshöller G, Flenker U, Piper T, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1728-1733. doi: 10.1002/dta.2498. Epub 2018 Oct 25.

PMID:
30230253
14.

Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication.

Gaunitz F, Lehmann S, Thomas A, Thevis M, Rothschild MA, Mercer-Chalmers-Bender K.

Int J Legal Med. 2018 Nov;132(6):1645-1657. doi: 10.1007/s00414-018-1911-8. Epub 2018 Sep 15. Erratum in: Int J Legal Med. 2018 Dec 5;:.

PMID:
30219927
15.

Updated protocols for the detection of Sotatercept and Luspatercept in human serum.

Reichel C, Gmeiner G, Walpurgis K, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1708-1713. doi: 10.1002/dta.2500. Epub 2018 Oct 1.

PMID:
30203930
16.

Response to letter to the editor: "Comments on Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone".

Forsdahl G, Geisendorfer T, Göschl L, Pfeffer S, Gärtner P, Thevis M, Gmeiner G.

Drug Test Anal. 2018 Aug 21. doi: 10.1002/dta.2486. [Epub ahead of print] No abstract available.

PMID:
30133177
17.

Erythropoietic effects of low-dose cobalt application.

Hoffmeister T, Schwenke D, Wachsmuth N, Krug O, Thevis M, Byrnes WC, Schmidt WFJ.

Drug Test Anal. 2018 Aug 15. doi: 10.1002/dta.2478. [Epub ahead of print]

PMID:
30110719
18.

Development and validation of a multidimensional gas chromatography/combustion/isotope ratio mass spectrometry-based test method for analyzing urinary steroids in doping controls.

Putz M, Piper T, Casilli A, Radler de Aquino Neto F, Pigozzo F, Thevis M.

Anal Chim Acta. 2018 Nov 7;1030:105-114. doi: 10.1016/j.aca.2018.05.016. Epub 2018 May 5.

PMID:
30032759
19.

Analysis of new growth promoting black market products.

Krug O, Thomas A, Malerød-Fjeld H, Dehnes Y, Laussmann T, Feldmann I, Sickmann A, Thevis M.

Growth Horm IGF Res. 2018 Aug;41:1-6. doi: 10.1016/j.ghir.2018.05.001. Epub 2018 May 19.

PMID:
29864719
20.

Effects of insulin and analogues on carcinogen-induced mammary tumours in high-fat-fed rats.

Mori Y, Ko E, Furrer R, Qu LC, Wiber SC, Fantus IG, Thevis M, Medline A, Giacca A.

Endocr Connect. 2018 May;7(5):739-748. doi: 10.1530/EC-17-0358. Epub 2018 Apr 24.

Supplemental Content

Loading ...
Support Center